Clinical utility of expanded carrier screening: results-guided actionability and outcomes

Genet Med. 2019 May;21(5):1041-1048. doi: 10.1038/s41436-018-0321-0. Epub 2018 Oct 11.

Abstract

Purpose: Expanded carrier screening (ECS) informs couples of their risk of having offspring affected by certain genetic conditions. Limited data exists assessing the actions and reproductive outcomes of at-risk couples (ARCs). We describe the impact of ECS on planned and actual pregnancy management in the largest sample of ARCs studied to date.

Methods: Couples who elected ECS and were found to be at high risk of having a pregnancy affected by at least one of 176 genetic conditions were invited to complete a survey about their actions and pregnancy management.

Results: Three hundred ninety-one ARCs completed the survey. Among those screened before becoming pregnant, 77% planned or pursued actions to avoid having affected offspring. Among those screened during pregnancy, 37% elected prenatal diagnostic testing (PNDx) for that pregnancy. In subsequent pregnancies that occurred in both the preconception and prenatal screening groups, PNDx was pursued in 29%. The decision to decline PNDx was most frequently based on the fear of procedure-related miscarriage, as well as the belief that termination would not be pursued in the event of a positive diagnosis.

Conclusion: ECS results impacted couples' reproductive decision-making and led to altered pregnancy management that effectively eliminates the risk of having affected offspring.

Keywords: at-risk couple.; clinical utility; expanded carrier screening; pregnancy management; prenatal diagnosis.

MeSH terms

  • Adult
  • Cohort Studies
  • Family Planning Services*
  • Female
  • Genetic Carrier Screening*
  • Genetic Counseling
  • Humans
  • Middle Aged
  • Pregnancy
  • Pregnancy Outcome
  • Prenatal Diagnosis
  • Surveys and Questionnaires